ArticleBioengineering (Basel, Switzerland)2024
RMCNet: A Liver Cancer Segmentation Network Based on 3D Multi-Scale Convolution, Attention, and Residual Path.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- DynTransNet: Dynamic Transformer Network with multi-scale attention for liver cancer segmentation.Frontiers in oncology · 2025Article
- A Unified Multi-Task Learning Model with Joint Reverse Optimization for Simultaneous Skin Lesion Segmentation and Diagnosis.Bioengineering (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Abdominal CT images are important clues for diagnosing liver cancer lesions. However, liver cancer presents challenges such as significant differences in tumor size, shape, and location, which can affect segmentation accuracy. To address these challenges, we propose an end-to-end 3D segmentation algorithm, RMCNet. In the shallow encoding part of RMCNet, we incorporated a 3D multiscale convolution (3D-Multiscale Convolution) module to more effectively extract tumors of varying sizes. Moreover, the convolutional block attention module (CBAM) is used in the encoding part to help the model focus on both the shape and location of tumors. Additionally, a residual path is introduced in each encoding layer to further enrich the extracted feature maps. Our method achieved DSC scores of 76.56% and 72.96%, JCC scores of 75.82% and 71.25%, HD values of 11.07 mm and 17.06 mm, and ASD values of 2.54 mm and 10.51 mm on the MICCAI 2017 Liver Tumor Segmentation public dataset and the 3Dircadb-01 public dataset, respectively. Compared to other methods, RMCNet demonstrates superior segmentation performance and stronger generalization capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.